Clinical Trials

“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database


0 +

Active Studies

0 +

Active Studies
Cancer Types


Cancer Types

Why join a clinical trial?

Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.

New clinical trials added on Sep 29, 2023

  • Assessing Social Determinants of Health to Increase Cancer Screening

    NCT Number : NCT06052449

  • Strength After Breast Cancer

    NCT Number : NCT06052488

  • A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men

    NCT Number : NCT06052202

  • NV-001 in the Treatment of Advanced Solid Tumors

    NCT Number : NCT06051760

  • SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology

    NCT Number : NCT06053086

  • ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

    NCT Number : NCT06052423

  • Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer

    NCT Number : NCT06052332

  • Music Breathing for Caregivers of Children Newly Diagnosed With Cancer

    NCT Number : NCT06052904

  • Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes

    NCT Number : NCT06052345

  • A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Men With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT Number : NCT06052306

  • Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer

    NCT Number : NCT06052098

  • A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

    NCT Number : NCT06051695

  • Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

    NCT Number : NCT06052839

  • A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

    NCT Number : NCT06052683

  • Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer

    NCT Number : NCT06051851

  • Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery

    NCT Number : NCT06052085

  • Study of BDC-3042 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Malignancies

    NCT Number : NCT06052852

  • Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

    NCT Number : NCT06052618

  • PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

    NCT Number : NCT06051942

  • Social Determinants of Health in Hepatobiliary Cancer Patients

    NCT Number : NCT06053333

  • A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)

    NCT Number : NCT06053099

  • Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL

    NCT Number : NCT06052696

  • Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors

    NCT Number : NCT06053268

  • A Multicenter RWS Study Comparing the Benefits of Continued Use of OFS After 5 Years

    NCT Number : NCT06050109

  • Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

    NCT Number : NCT06043973

  • A Study of BN104 in the Treatment of Acute Leukemia

    NCT Number : NCT06052813

  • Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

    NCT Number : NCT06052826

  • Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea)

    NCT Number : NCT06051747

  • A Study to Evaluate Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

    NCT Number : NCT06052059

  • Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.

    NCT Number : NCT06053567

  • A Study of Adipose Tissue in Adaptive Responses to Exercise

    NCT Number : NCT06053125

  • Turkish Version of the Worry About Pain Questionnaire

    NCT Number : NCT06052228

  • The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

    NCT Number : NCT06043908

  • Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 (THYTECH2)

    NCT Number : NCT06052436

  • Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

    NCT Number : NCT04551131

  • Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

    NCT Number : NCT06052033

  • Somatic Mosaicism in Twins Discordant for Childhood Cancer

    NCT Number : NCT06054295

  • Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)

    NCT Number : NCT06054854

  • A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors

    NCT Number : NCT06055166

  • Multisite Implementation of COMPRENDO

    NCT Number : NCT06055296

  • Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study

    NCT Number : NCT06054308

  • SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

    NCT Number : NCT06055348

  • PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

    NCT Number : NCT06054867

  • Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer

    NCT Number : NCT06055465

  • A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

    NCT Number : NCT06055439

  • Study of ALE.C04 in Patients With Head and Neck Cancer

    NCT Number : NCT06054477

  • Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)

    NCT Number : NCT06053775

  • Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

    NCT Number : NCT06053658

  • Hepatopulmonary Radio-sterilization With Immunotherapy

    NCT Number : NCT06053996

  • TCR-T Cells in the Treatment of Advanced Pancreatic Cancer

    NCT Number : NCT06054984

  • Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

    NCT Number : NCT06054789

  • Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer

    NCT Number : NCT06054906

  • Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

    NCT Number : NCT06054529

  • Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

    NCT Number : NCT06054776

  • Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

    NCT Number : NCT06055010

  • Frailty Assessment and Intervention in Elderly Patients With Gastric Cancer Receiving Gastrectomy and Adjuvant Chemotherapy

    NCT Number : NCT06055387

  • Hand-Foot Exercises on Peripheral Neuropathy

    NCT Number : NCT06055088

  • Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors

    NCT Number : NCT06054932

  • Association Between Body Composition and Digestive System Cancer Survival

    NCT Number : NCT06054685

  • PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis

    NCT Number : NCT06055231

  • Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations

    NCT Number : NCT06054191

  • A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

    NCT Number : NCT06055075

  • Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible

    NCT Number : NCT06055257

  • Identification of Nerves Using Fluorescein Sodium

    NCT Number : NCT06054178

  • CX3CR1+T Cell Predict Immunotherapy Efficacy

    NCT Number : NCT06054152

  • Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)

    NCT Number : NCT06055517

  • DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC

    NCT Number : NCT06055153

  • A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

    NCT Number : NCT06053801

  • Reshaping Postpartum Follow-up

    NCT Number : NCT06054841

  • XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)

    NCT Number : NCT06055179

  • Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients

    NCT Number : NCT06055543

  • The Effect of Bed Bath Applied to Palliative Care Patients on Saturation, Pain Level and Sleep Quality

    NCT Number : NCT06055426

  • Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing Age

    NCT Number : NCT06055114

  • Effects of Intradialytic Aerobic Exercise in Chronic Kidney Patients

    NCT Number : NCT06055283

  • Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

    NCT Number : NCT06054113

  • A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

    NCT Number : NCT06054555

  • Effect of Short-chain Fatty Acids on Aerobic Endurance

    NCT Number : NCT06054607

  • Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    NCT Number : NCT06058377

  • Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR

    NCT Number : NCT06057350

  • PET/MRI in Rectal Cancer

    NCT Number : NCT06057831

  • Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

    NCT Number : NCT06059118

  • Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

    NCT Number : NCT06056804

  • IMaC - Immune Pathways in Oesophagogastric Cancer

    NCT Number : NCT06057220

  • A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

    NCT Number : NCT06057038

  • Heart Health After Cancer Treatment (HEART-ACT)

    NCT Number : NCT06055803

  • Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy.

    NCT Number : NCT06056830

  • Exercises Using Virtual Reality on Cancer Patients

    NCT Number : NCT06058936

  • A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer

    NCT Number : NCT06057610

  • A Study of HB0045 Injection in Patients With Advanced Solid Tumors

    NCT Number : NCT06056323

  • Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer

    NCT Number : NCT06059014

  • Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer

    NCT Number : NCT06057766

  • A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

    NCT Number : NCT06056024

  • Study of INKmune in Patients With mCRPC (CaRe Prostate)

    NCT Number : NCT06056791

  • Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors

    NCT Number : NCT06059508

  • Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study

    NCT Number : NCT06059495

  • Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

    NCT Number : NCT06059261

  • The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology

    NCT Number : NCT06059651

  • INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) for the Treatment of Advanced or Metastatic PD-(L)1 Refractory Merkle Cell Carcinoma

    NCT Number : NCT06056895

  • People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

    NCT Number : NCT06055868

  • Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

    NCT Number : NCT06056310

  • Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

    NCT Number : NCT06058793

  • Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

    NCT Number : NCT06058988

  • Radioembolization With Tremelimumab and Durvalumab for Locally Advanced, Unresectable Intrahepatic Cholangiocarcinoma

    NCT Number : NCT06058663

  • Evaluation of Intra- and Peri-operative Complications and Disease-free Survival in Rectal Cancer Patients Undergoing Oncological Resective Surgery and Concomitant Bariatric Surgery

    NCT Number : NCT06056726

  • Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy

    NCT Number : NCT06056505

  • Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE

    NCT Number : NCT06055621

  • Nutritional Intervention for Patients With Multiple Cancer Types

    NCT Number : NCT06059560

  • A Study YL201 in Patients With Selected Advanced Solid Tumors

    NCT Number : NCT06057922

  • Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy

    NCT Number : NCT06055946

  • Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists

    NCT Number : NCT06056843

  • Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

    NCT Number : NCT06059001

  • Individual Food Preferences for the Mediterranean Diet in Cancer Patients

    NCT Number : NCT06058312

  • Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

    NCT Number : NCT06057636

  • Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

    NCT Number : NCT06055738

  • Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

    NCT Number : NCT03896646

  • Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation

    NCT Number : NCT06056414

  • PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.

    NCT Number : NCT06059469

  • Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer

    NCT Number : NCT06059547

  • Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

    NCT Number : NCT06056362

  • Project Looking-Glass Evaluation

    NCT Number : NCT06056063

  • Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health

    NCT Number : NCT06055972

  • Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

    NCT Number : NCT01709435

  • Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS)

    NCT Number : NCT06055881

  • Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

    NCT Number : NCT06059586

  • Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)

    NCT Number : NCT06057298

  • Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma

    NCT Number : NCT06060080

  • A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

    NCT Number : NCT06058741

  • Impact of Augmented Reality During Robot-assisted Radical Prostatectomy

    NCT Number : NCT06059859

  • Multiple Myeloma Yoga Pilot Study

    NCT Number : NCT06061302

  • Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

    NCT Number : NCT06055816

  • Tranexamic Acid in Nasal Mohs Reconstruction

    NCT Number : NCT06057675

  • Confirmation of Accuracy of the Tool-in-lesion Technology (TiLT) of the Galaxy System With Integrated TOMO Technology

    NCT Number : NCT06056128

  • Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

    NCT Number : NCT06055790

  • Safety and Efficacy of OBX-115 in Advanced/Metastatic Melanoma Resistant to Immune Checkpoint Inhibitors

    NCT Number : NCT06060613

  • CPX-351 Plus Enasidenib for Relapsed AML

    NCT Number : NCT03825796

  • Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging

    NCT Number : NCT06060769

  • Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

    NCT Number : NCT06058650

  • CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

    NCT Number : NCT06059391

  • Endoscopic Ultrasound- Guided Hartmann Reversal Procedure

    NCT Number : NCT06061432

  • Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

    NCT Number : NCT06056115

  • The Pancreatic Enzymes After Gastrectomy Trial

    NCT Number : NCT06058442

  • New Method to Differentiate Benign and Malignant Pulmonary Nodules.

    NCT Number : NCT06056999

  • A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

    NCT Number : NCT06057948

  • A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

    NCT Number : NCT06057935

  • A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)

    NCT Number : NCT06055894

  • Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia

    NCT Number : NCT06058572

  • Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas

    NCT Number : NCT06057168

  • Adapting, Expanding and Evaluating ARCHES in Kenya

    NCT Number : NCT06059196

  • Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy

    NCT Number : NCT06060561

  • Omega Gastric Bypass (150cm) Compared to the Roux-en-Y Gastric Bypass

    NCT Number : NCT06057597

  • Serum Magnesium Level in Type 2 Diabetes Mellitus

    NCT Number : NCT06059833

  • Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis

    NCT Number : NCT06055699

  • Project OASIS: Optimizing Approaches to Select Implementation Strategies

    NCT Number : NCT06061328

  • The Effects of Aronia Melanocarpa Extract on Obese Individuals With Impaired Fasting Blood Glucose

    NCT Number : NCT06057389

  • A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

    NCT Number : NCT06058728

  • Role of FDG PET/CT in Patients With Metastasis of Unknown Origin

    NCT Number : NCT06055764

  • Intraoperative Blood Loss Under Standard Versus Low Pneumoperitoneum Pressure During Laparoscopic Liver Resection.

    NCT Number : NCT06060899

  • Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

    NCT Number : NCT06058858

  • Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning

    NCT Number : NCT06061835

  • Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

    NCT Number : NCT06056336

  • The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain

    NCT Number : NCT06060028

  • Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

    NCT Number : NCT06057402

  • Digital Tool Enhancing GPs' Information Management for Patients With Multimorbidity - a Pilot Study

    NCT Number : NCT06061172

  • Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

    NCT Number : NCT06061094

  • Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

    NCT Number : NCT06057571

  • Shwachman Diamond Syndrome Registry and Study

    NCT Number : NCT06056908

  • SIRT1(rs7069102 ) Gene Polymorphism in Chronic Obstructive Pulmonary Disease at Egyptian Patients

    NCT Number : NCT06055634

  • Effect of Indoor Plants on Cardiopulmonary System

    NCT Number : NCT06060145

  • Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy

    NCT Number : NCT06056687

  • Gut Microbiota in Metabolic Surgery

    NCT Number : NCT05000996

  • Bruni® Training in OPHL Patients

    NCT Number : NCT06058273

  • Lamivudine and Plasma Markers of Inflammation in Retinal Detachment

    NCT Number : NCT06056596

  • Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

    NCT Number : NCT06060782

  • Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes

    NCT Number : NCT06057246

  • QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

    NCT Number : NCT06056752

  • LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs

    NCT Number : NCT06060912

  • N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

    NCT Number : NCT06061809

  • Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

    NCT Number : NCT06055998

  • A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

    NCT Number : NCT06055959


    NCT Number : NCT06056635

  • Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

    NCT Number : NCT06056921

  • A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM)

    NCT Number : NCT05489705

  • inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease

    NCT Number : NCT06059989

  • Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules

    NCT Number : NCT06056882

  • Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)

    NCT Number : NCT06060847

Want alerts of new clinical trials into your email inbox? Subscribe today

Find a Trial

Enter a few details below to get started and we'll help you match up with active clinical trials

Cancer Details

9097 Trials found

Cancer Details

Eligibility Criteria


OncoPower Clinical Trial Features

OncoPower Clinical Trial Features


Clinical Trial Matching

Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you


Eligiblity Verification

We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria


Reimbursement Options

Our team will connect you with financial resources available to clinical trial participants


Trial Sponsor Coordination

OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial

FAQs For Patients

Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.

There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).

Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.

You are able to leave a clinical trial at any time, for any reason.

Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.

Create Your Free Account Today

Begin offering a comprehensive digital experience for your patients.